Johnson & Johnson Reports Q3 2021 Results
New Brunswick, N.J. (October 19, 2021) – Johnson &Johnson (NYSE: JNJ) today announced results for third-quarter 2021. “Our third-quarter results demonstrate solid performance across Johnson &Johnson, driven by robust above-market results in Pharmaceuticals, ongoing recovery in Medical Devices, and strong growth in Consumer Health,” said Alex Gorsky, Chairman and Chief Executive Officer. “In the face of evolving marketplace dynamics resulting from the effects of COVID-19 and other global trends, we have continued to demonstrate the responsiveness and agility required to meet the needs of our stakeholders, while also successfully investing in a pipeline of innovation and key commercial platforms to drive our future growth. I am incredibly proud of our Company’s transformative growth over the last decade. As I prepare to transition the role of CEO to Joaquin Duato in January, I want to extend my deepest gratitude to our colleagues around the globe who work tirelessly to deliver solutions to address the world’s most urgent and unmet healthcare challenges.” OVERALL FINANCIAL RESULTS expand 1 Non-GAAP financial measure; refer to reconciliations of non-GAAP financial measures included in accompanying schedules 2 Excludes the impact of translational currency 3 Excludes the net impact of acquisitions and divestitures and translational currency 4 Excludes intangible amortization expense and special itemsREGIONA...
Papers released by SAGE and subgroup Nervtag warned the highly evolved Omicron super mutant strain could cause a surge in cases 'similar or even larger' than previous waves.
Brazilian President Jair Bolsonaro is facing a potential investigation into comments linking COVID-19 vaccines to AIDS
The White House COVID-19 Response Team announced steps to fortify public health protection before onset of winter and the potential increasing circulation of Omicron.Medscape Medical News
If the finding holds up elsewhere, Omicron may be more difficult to contain than previous iterations of the coronavirus, lengthening the pandemic.
A new mathematical analysis strengthens concerns about the effects of the new variant on the pandemic ’s course.
The arrival of the omicron variant of the coronavirus has health officials in some U.S. communities reviving contact tracing operations in an attempt to slow and understand its spread
This is the FDA ’s first emergency use authorization of a Covid-19 monoclonal antibody treatment in kids as young as newborns.
Officials say a male resident in his 30's from Northwest Philadelphia has tested positive for the omicron variant. #northwestphiladelphia #omicronvariant
Wall Street's major indexes fell in choppy trading on Friday, with the Nasdaq tumblingmore than 2%, as mixed jobs data, uncertainty around the Omicron coronavirus variant and the path of the... #tumblingmore #policytightening #federalreserve
UNTREATED diabetes can cause permanent damage to the feet that can render it vulnerable to gangrene. This can lead to toe amputation if left untreated.
More News: Arthritis | Aspirin | Canagliflozin | Cancer | Cancer & Oncology | Cancer Vaccines | Cardiology | Colorectal Cancer | Conferences | COVID-19 | Diabetes | Diabetes Type 2 | Emergency Medicine | Endocrinology | Environmental Health | Government | Health Management | Heart | Hypertension | Ibuprofen | Invega | Invega Sustenna | Invokana | Legislation | Lung Cancer | Medical Devices | Medical Ethics | Myeloma | Non-Small Cell Lung Cancer | Oral Cancer | Orthopaedics | Outbreaks | Pandemics | Pediatrics | Peripheral Vascular Disease (PVD) | Pharmaceuticals | Podcasts | Profits and Losses | Prostate Cancer | Psoriasis | Psoriatic Arthritis | Remicade | Respiratory Medicine | Rheumatology | SARS | Schizophrenia | Science | Skin | Sports Medicine | Stelara | Strategic Planning | Surgery | Vaccines | Websites